Science Explorer Back to mapMap
Discussion
Researcher · Patient Advocate Foundation · United States

Rebekah Angove

Rebekah Angove publishes mostly in Economics and Econometrics, General Health Professions and Oncology, on topics such as Economic and Financial Impacts of Cancer, Health Systems, Economic Evaluations, Quality of Life and Healthcare Policy and Management.

ORCID 0000-0003-3832-1670 OpenAlex
World rank
#1,472,789
of 7,710,434 ranked researchers
Rank in United States
#462,621
of 1,627,098
Works
64
Citations
380
Citations per work
5.9
h-index
12
i10-index 14Top 27% in Economics and Econometrics
Rebekah Angove

What does Rebekah Angove research?

Rebekah Angove's work is mostly in Economics, Econometrics and Finance (32%), Medicine (23%), Health Professions (23%).

Health Sciences: 29 works · 45.9% of their workMedicine: 15 works · 23.2% of their workOncology: 6 works · 9.3% of their workPublic Health, Environmental and Occupational Health: 5 works · 7.3% of their workEpidemiology: 2 works · 3.3% of their workPediatrics, Perinatology and Child Health: 2 works · 3.3% of their workHealth Professions: 15 works · 22.7% of their workGeneral Health Professions: 15 works · 22.7% of their workSocial Sciences: 20 works · 32.0% of their workEconomics, Econometrics and Finance: 20 works · 32.0% of their workEconomics and Econometrics: 20 works · 32.0% of their workEverything else: 14 works · 22.1% of their workTHEIR WORKRebekah Angove64works
Health Sciences46%Social Sciences32%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1523.2%
    2. Health Professions1522.7%
    1. Economics, Econometrics and Finance2032.0%
  3. Everything else1422.1%
  1. 1Economics and Econometrics32% of their works
  2. 2General Health Professions23% of their works
  3. 3Oncology9% of their works
  4. 4Public Health, Environmental and Occupational Health7% of their works
  5. 5Epidemiology3% of their works
  6. 6Pediatrics, Perinatology and Child Health3% of their works

Research topics

Which keywords describe Rebekah Angove's research?

The keywords of their largest research topics: Cost of Care, Financial Toxicity, Quality of Life, Clinical Trials, Cost-effectiveness Analysis, Health Utility Measures, Health Care Spending and Insurance Markets.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 18 words, with their numbers
  1. Cost of Care291 topic
  2. Financial Toxicity291 topic
  3. Quality of Life152 topics
  4. Clinical Trials142 topics
  5. Cost-effectiveness Analysis101 topic
  6. Health Utility Measures101 topic
  7. Health Care Spending91 topic
  8. Insurance Markets91 topic
  9. COVID-1971 topic
  10. Cancer71 topic
  11. Informed Consent71 topic
  12. Patient Engagement71 topic
  13. Public Involvement71 topic
  14. Research Participation71 topic
  15. Cancer Survivorship51 topic
  16. Implementation Science51 topic
  17. Patient-Reported Outcomes51 topic
  18. Qualitative Research51 topic

Where does Rebekah Angove work?

Rebekah Angove's main affiliation in the publication record is Patient Advocate Foundation, United States.

How many publications and citations does Rebekah Angove have?

OpenAlex counts 64 works and 380 citations for Rebekah Angove, an h-index of 12, ranking #1,472,789 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Rebekah Angove. Posts are plain text and can be reported.